Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aikaterini Bilitou

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 29, 2010
The role of cell cycle in retinal development: cyclin-dependent kinase inhibitors co-ordinate cell-cycle inhibition, cell-fate determination and differentiation in the developing retinaAikaterini Bilitou, Shin-ichi Ohnuma
Molecular and Cellular Biochemistry|May 8, 2009
The NM23 family in developmentAikaterini Bilitou, Julie Watson, Anton Gartner, et al.
Plos One|October 27, 2022
Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular riskJulius L Katzmann, Christian Becker, Aikaterini Bilitou, et al.
Clinical Drug Investigation|September 20, 2015
Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare settingKostas Athanasakis, Eleftheria Karampli, Dimitrios Tsounis, et al.
The Journal of Headache and Pain|September 12, 2018
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United KingdomPamela Vo, Juanzhi Fang, Aikaterini Bilitou, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 25, 2016
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek PerspectiveKostas Athanasakis, Nadia Boubouchairopoulou, Eleftheria Karampli, et al.
Neural Development|January 7, 2009
Xenopus NM23-X4 regulates retinal gliogenesis through interaction with p27Xic1Toshiaki Mochizuki, Aikaterini Bilitou, Caroline T Waters, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 28, 2016
Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for GreeceKostas Athanasakis, Aikaterini Bilitou, Dawn Lee, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 12, 2022
Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019Aikaterini Bilitou, John Were, Archie Farrer, et al.
Frontiers in Pharmacology|August 15, 2020
Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other CancersMaribel Salas, Mackenzie Henderson, Angelika Wientzek-Fleischmann, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 29, 2010
The role of cell cycle in retinal development: cyclin-dependent kinase inhibitors co-ordinate cell-cycle inhibition, cell-fate determination and differentiation in the developing retinaAikaterini Bilitou, Shin-ichi Ohnuma
Molecular and Cellular Biochemistry|May 8, 2009
The NM23 family in developmentAikaterini Bilitou, Julie Watson, Anton Gartner, et al.
Plos One|October 27, 2022
Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular riskJulius L Katzmann, Christian Becker, Aikaterini Bilitou, et al.
Clinical Drug Investigation|September 20, 2015
Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare settingKostas Athanasakis, Eleftheria Karampli, Dimitrios Tsounis, et al.
The Journal of Headache and Pain|September 12, 2018
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United KingdomPamela Vo, Juanzhi Fang, Aikaterini Bilitou, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 25, 2016
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek PerspectiveKostas Athanasakis, Nadia Boubouchairopoulou, Eleftheria Karampli, et al.
Neural Development|January 7, 2009
Xenopus NM23-X4 regulates retinal gliogenesis through interaction with p27Xic1Toshiaki Mochizuki, Aikaterini Bilitou, Caroline T Waters, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 28, 2016
Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for GreeceKostas Athanasakis, Aikaterini Bilitou, Dawn Lee, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 12, 2022
Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019Aikaterini Bilitou, John Were, Archie Farrer, et al.
Frontiers in Pharmacology|August 15, 2020
Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other CancersMaribel Salas, Mackenzie Henderson, Angelika Wientzek-Fleischmann, et al.
Pageof 2